Payment Breakdown by Category
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $1,799 | 123 | 99.4% |
| Education | $10.52 | 1 | 0.6% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| GlaxoSmithKline, LLC. | $467.25 | 35 | $0 (2024) |
| AstraZeneca Pharmaceuticals LP | $225.75 | 15 | $0 (2024) |
| PFIZER INC. | $195.87 | 12 | $0 (2024) |
| E.R. Squibb & Sons, L.L.C. | $134.66 | 8 | $0 (2024) |
| Takeda Pharmaceuticals U.S.A., Inc. | $99.38 | 8 | $0 (2020) |
| Janssen Pharmaceuticals, Inc | $82.06 | 6 | $0 (2020) |
| Merck Sharp & Dohme LLC | $75.11 | 6 | $0 (2024) |
| Sumitomo Pharma America, Inc. | $71.36 | 3 | $0 (2024) |
| Allergan, Inc. | $70.04 | 5 | $0 (2020) |
| ABBVIE INC. | $66.83 | 4 | $0 (2024) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $421.79 | 23 | PFIZER INC. ($87.27) |
| 2023 | $221.53 | 12 | PFIZER INC. ($58.12) |
| 2022 | $89.72 | 5 | AstraZeneca Pharmaceuticals LP ($37.56) |
| 2021 | $12.69 | 1 | GlaxoSmithKline, LLC. ($12.69) |
| 2020 | $151.88 | 10 | GlaxoSmithKline, LLC. ($66.05) |
| 2019 | $385.25 | 30 | GlaxoSmithKline, LLC. ($118.71) |
| 2018 | $329.58 | 26 | GlaxoSmithKline, LLC. ($107.62) |
| 2017 | $197.23 | 17 | GlaxoSmithKline, LLC. ($68.35) |
All Payment Transactions
124 individual payment records from CMS Open Payments — Page 1 of 5
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/06/2024 | E.R. Squibb & Sons, L.L.C. | CAMZYOS (Drug) | Food and Beverage | Cash or cash equivalent | $15.23 | General |
| Category: Cardiovascular | ||||||
| 11/22/2024 | Exact Sciences Corporation | Cologuard Collection Kit (Device) | Food and Beverage | In-kind items and services | $22.79 | General |
| Category: Oncology | ||||||
| 11/15/2024 | AstraZeneca Pharmaceuticals LP | AIRSUPRA (Drug) | Food and Beverage | In-kind items and services | $15.47 | General |
| Category: Respiratory | ||||||
| 10/26/2024 | PFIZER INC. | PREVNAR 20 (Biological), COMIRNATY, ABRYSVO | Food and Beverage | In-kind items and services | $18.99 | General |
| Category: VACCINES | ||||||
| 10/11/2024 | Sumitomo Pharma America, Inc. | GEMTESA (Drug) | Food and Beverage | In-kind items and services | $23.61 | General |
| Category: UROLOGY | ||||||
| 09/27/2024 | Astellas Pharma US Inc | Veozah (Drug) | Food and Beverage | In-kind items and services | $20.38 | General |
| Category: Biological | ||||||
| 09/20/2024 | E.R. Squibb & Sons, L.L.C. | CAMZYOS (Drug) | Food and Beverage | Cash or cash equivalent | $14.27 | General |
| Category: Cardiovascular | ||||||
| 09/13/2024 | Merck Sharp & Dohme LLC | GARDASIL (Biological), CAPVAXIVE, GARDASIL 9 | Food and Beverage | In-kind items and services | $13.61 | General |
| Category: VACCINE | ||||||
| 09/06/2024 | GlaxoSmithKline, LLC. | AREXVY (Drug), TRELEGY ELLIPTA | Food and Beverage | In-kind items and services | $28.42 | General |
| Category: RESPIRATORY | ||||||
| 08/26/2024 | E.R. Squibb & Sons, L.L.C. | CAMZYOS (Drug) | Food and Beverage | Cash or cash equivalent | $17.92 | General |
| Category: Cardiovascular | ||||||
| 08/01/2024 | PFIZER INC. | NURTEC ODT (Drug), ZAVZPRET | Food and Beverage | In-kind items and services | $15.21 | General |
| Category: PAIN | ||||||
| 06/27/2024 | PFIZER INC. | ELIQUIS (Drug), NURTEC ODT | Food and Beverage | In-kind items and services | $16.10 | General |
| Category: CARDIOVASCULAR;METABOLIC DISEASE | ||||||
| 06/21/2024 | GlaxoSmithKline, LLC. | TRELEGY ELLIPTA (Drug), AREXVY | Food and Beverage | In-kind items and services | $16.00 | General |
| Category: RESPIRATORY | ||||||
| 05/30/2024 | Astellas Pharma US Inc | Veozah (Drug) | Food and Beverage | In-kind items and services | $17.07 | General |
| Category: Biological | ||||||
| 05/28/2024 | Novo Nordisk Inc | Rybelsus (Drug), Ozempic | Food and Beverage | In-kind items and services | $19.75 | General |
| Category: Diabetes | ||||||
| 05/14/2024 | Exact Sciences Corporation | Cologuard Collection Kit (Device) | Food and Beverage | In-kind items and services | $16.50 | General |
| Category: Oncology | ||||||
| 05/02/2024 | ABBVIE INC. | CREON (Drug), LINZESS | Food and Beverage | In-kind items and services | $15.98 | General |
| Category: ENDOCRINOLOGY | ||||||
| 04/04/2024 | PFIZER INC. | NURTEC ODT (Drug), ZAVZPRET | Food and Beverage | In-kind items and services | $22.80 | General |
| Category: PAIN | ||||||
| 03/28/2024 | GlaxoSmithKline, LLC. | TRELEGY ELLIPTA (Drug) | Food and Beverage | In-kind items and services | $16.78 | General |
| Category: RESPIRATORY | ||||||
| 03/21/2024 | AstraZeneca Pharmaceuticals LP | — | Food and Beverage | In-kind items and services | $20.86 | General |
| 02/29/2024 | Sumitomo Pharma America, Inc. | GEMTESA (Drug) | Food and Beverage | In-kind items and services | $24.85 | General |
| Category: UROLOGY | ||||||
| 02/15/2024 | AstraZeneca Pharmaceuticals LP | FARXIGA (Drug) | Food and Beverage | In-kind items and services | $15.03 | General |
| Category: Cardiovascular and Metabolism | ||||||
| 01/11/2024 | PFIZER INC. | NURTEC ODT (Drug), ZAVZPRET | Food and Beverage | In-kind items and services | $14.17 | General |
| Category: PAIN | ||||||
| 11/09/2023 | E.R. Squibb & Sons, L.L.C. | CAMZYOS (Drug) | Food and Beverage | Cash or cash equivalent | $23.88 | General |
| Category: Cardiovascular | ||||||
| 10/26/2023 | PFIZER INC. | PAXLOVID (Drug) | Food and Beverage | In-kind items and services | $24.99 | General |
| Category: INFECTIOUS DISEASES | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 13 | 1,132 | 2,257 | $521,028 | $156,980 |
| 2022 | 16 | 1,316 | 2,334 | $500,965 | $152,916 |
| 2021 | 15 | 1,225 | 2,131 | $371,626 | $140,851 |
| 2020 | 16 | 1,242 | 2,261 | $322,727 | $114,768 |
All Medicare Procedures & Services
60 procedure records from CMS Medicare Utilization — Page 1 of 3
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 478 | 1,045 | $313,500 | $92,333 | 29.5% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 390 | 659 | $144,980 | $40,403 | 27.9% |
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Office | 2023 | 37 | 42 | $16,800 | $6,037 | 35.9% |
| 99495 | Transitional care management services for problem of at least moderate complexity | Office | 2023 | 27 | 32 | $11,200 | $5,337 | 47.7% |
| 99496 | Transitional care management services for problem of high complexity | Office | 2023 | 19 | 20 | $10,000 | $4,341 | 43.4% |
| G0180 | Physician or allowed practitioner certification for medicare-covered home health services under a home health plan of care (patient not present), including contacts with home health agency and review of reports of patient status required by physicians and | Office | 2023 | 38 | 56 | $4,760 | $2,266 | 47.6% |
| G0439 | Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 2023 | 13 | 13 | $2,340 | $1,714 | 73.3% |
| 96372 | Injection of drug or substance under skin or into muscle | Office | 2023 | 18 | 142 | $6,390 | $1,391 | 21.8% |
| 99203 | New patient office or other outpatient visit, 30-44 minutes | Office | 2023 | 12 | 12 | $2,280 | $1,002 | 44.0% |
| 69210 | Removal of impacted ear wax | Office | 2023 | 22 | 24 | $2,088 | $738.72 | 35.4% |
| 99497 | Advance care planning, first 30 minutes | Office | 2023 | 13 | 13 | $1,170 | $735.57 | 62.9% |
| 93000 | Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report | Office | 2023 | 47 | 54 | $3,780 | $531.90 | 14.1% |
| J3420 | Injection, vitamin b-12 cyanocobalamin, up to 1000 mcg | Office | 2023 | 18 | 145 | $1,740 | $150.09 | 8.6% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 463 | 912 | $273,600 | $80,712 | 29.5% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 413 | 699 | $153,780 | $42,906 | 27.9% |
| 99495 | Transitional care management services for problem of moderate complexity | Office | 2022 | 32 | 35 | $12,250 | $6,006 | 49.0% |
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Office | 2022 | 32 | 35 | $14,000 | $4,642 | 33.2% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2022 | 31 | 31 | $7,440 | $3,316 | 44.6% |
| G0180 | Physician or allowed practitioner certification for medicare-covered home health services under a home health plan of care (patient not present), including contacts with home health agency and review of reports of patient status required by physicians and | Office | 2022 | 48 | 70 | $5,950 | $2,971 | 49.9% |
| 99203 | New patient office or other outpatient visit, 30-44 minutes | Office | 2022 | 27 | 27 | $5,130 | $2,182 | 42.5% |
| G0439 | Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 2022 | 15 | 15 | $2,700 | $2,055 | 76.1% |
| G0008 | Administration of influenza virus vaccine | Office | 2022 | 48 | 48 | $3,360 | $1,617 | 48.1% |
| 96372 | Injection of drug or substance under skin or into muscle | Office | 2022 | 19 | 140 | $6,300 | $1,455 | 23.1% |
| 99443 | Telephone medical discussion with physician, 21-30 minutes | Office | 2022 | 11 | 11 | $2,090 | $1,104 | 52.8% |
| 99442 | Telephone medical discussion with physician, 11-20 minutes | Office | 2022 | 17 | 18 | $2,880 | $1,052 | 36.5% |
About Dr. Christine Baker, MD
Dr. Christine Baker, MD is a Internal Medicine healthcare provider based in Northampton, Massachusetts. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 01/11/2006. The National Provider Identifier (NPI) number assigned to this provider is 1518946359.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Christine Baker, MD has received a total of $1,810 in payments from pharmaceutical and medical device companies, with $421.79 received in 2024. These payments were reported across 124 transactions from 19 companies. The most common payment nature is "Food and Beverage" ($1,799).
As a Medicare-enrolled provider, Baker has provided services to 4,915 Medicare beneficiaries, totaling 8,983 services with total Medicare billing of $565,514. Data is available for 4 years (2020–2023), covering 60 distinct procedure/service records.
Practice Information
- Specialty Internal Medicine
- Location Northampton, MA
- Active Since 01/11/2006
- Last Updated 07/08/2007
- Taxonomy Code 207R00000X
- Entity Type Individual
- NPI Number 1518946359
Products in Payments
- TRELEGY ELLIPTA (Drug) $273.23
- ELIQUIS (Drug) $108.39
- FARXIGA (Drug) $87.86
- GEMTESA (Drug) $71.36
- CAMZYOS (Drug) $71.30
- SYMBICORT (Drug) $64.00
- ENTRESTO (Drug) $59.92
- Trintellix (Drug) $54.95
- Amitiza (Drug) $53.58
- NURTEC ODT (Drug) $52.18
- XARELTO (Drug) $50.55
- JANUVIA (Drug) $50.12
- ANORO ELLIPTA (Drug) $46.58
- BREO (Drug) $41.68
- VRAYLAR (Drug) $39.57
- Cologuard Collection Kit (Device) $39.29
- Veozah (Drug) $37.45
- QULIPTA (Drug) $37.26
- Ozempic (Drug) $32.26
- UBRELVY (Drug) $32.08
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Internal Medicine Doctors in Northampton
Dr. Jay Fleitman, Md, MD
Internal Medicine — Payments: $46,677
Iqbal Sorathia, Md, MD
Internal Medicine — Payments: $1,238
Meena Agarwala, Md, MD
Internal Medicine — Payments: $956.11
Angeles Gonzalez-Prado, Md, MD
Internal Medicine — Payments: $288.35
Dr. Winthrop Whitcomb, Md, MD
Internal Medicine — Payments: $245.22
Bruce Weinraub, Md, MD
Internal Medicine — Payments: $166.65